Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 ,inter alia, to consider and approve Board Meeting Intimation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Ltd has informed BSE that its Board of Directors will meet on Monday, May 12, 2025 at the registered office. The key agenda items are: (1) approval of audited standalone and consolidated financial results for the quarter and full year ended March 31, 2025, (2) approval of audited standalone and consolidated financial statements for FY25, and (3) consideration and recommendation of a final dividend, if any, for FY25. The trading window for designated persons is already closed since April 1, 2025 and will reopen 48 hours after results are declared. This is a routine procedural filing ahead of the FY25 results announcement.
This is a standard pre-results intimation with no new financial information. Investors should watch the May 12 meeting for the actual FY25 results and any decision on final dividend, which could influence short-term stock movement.